Anna Kawiak

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 16

Top Topics

Pseudomonas Aeruginosa

Breast Cancer Cells

Endoplasmic Reticulum Stress

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Kawiak
Molecular Research and Treatment of Breast Cancer 2.0. International journal of molecular sciences 25 (7) (2024)
Anna Kawiak
Molecular Research and Treatment of Breast Cancer 2.0. International journal of molecular sciences 25 (7) (2024)
Aneta Pogorzelska, Jarosław Sławiński, Anna Kawiak, Grzegorz Stasiłojć, Jarosław Chojnacki
Synthesis of 3-(2-Alkylthio-4-chloro-5-methylbenzenesulfonyl)-2-(1-phenyl-3-arylprop-2-enylideneamino)guanidine Derivatives with Pro-Apoptotic Activity against Cancer Cells. International journal of molecular sciences 24 (5) (2023)
Beata Żołnowska, Jarosław Sławiński, Mariusz Belka, Tomasz Ba Czek, Jarosław Chojnacki, Anna Kawiak
Novel 2-alkythio-4-chloro- N -[imino(heteroaryl)methyl]benzenesulfonamide Derivatives: Synthesis, Molecular Structure, Anticancer Activity and Metabolic Stability. International journal of molecular sciences 24 (11) (2023)
Aneta Pogorzelska, Jarosław Sławiński, Anna Kawiak, Grzegorz Stasiłojć, Jarosław Chojnacki
Synthesis of 3-(2-Alkylthio-4-chloro-5-methylbenzenesulfonyl)-2-(1-phenyl-3-arylprop-2-enylideneamino)guanidine Derivatives with Pro-Apoptotic Activity against Cancer Cells. International journal of molecular sciences 24 (5) (2023)
Aneta Pogorzelska, Jarosław Sławiński, Anna Kawiak, Grzegorz Stasiłojć, Jarosław Chojnacki
Synthesis of 3-(2-Alkylthio-4-chloro-5-methylbenzenesulfonyl)-2-(1-phenyl-3-arylprop-2-enylideneamino)guanidine Derivatives with Pro-Apoptotic Activity against Cancer Cells. International journal of molecular sciences 24 (5) (2023)
Anna Kawiak
Molecular Research and Treatment of Breast Cancer. International journal of molecular sciences 23 (17) (2022)
Anna Kawiak, Anna Kostecka
Regulation of Bcl-2 Family Proteins in Estrogen Receptor-Positive Breast Cancer and Their Implications in Endocrine Therapy. Cancers 14 (2) (2022)
Paulina Mech-Warda, Artur Giełdoń, Anna Kawiak, Natalia Maciejewska, Mateusz Olszewski, Mariusz Makowski, Agnieszka Chylewska
Low-Molecular Pyrazine-Based DNA Binders: Physicochemical and Antimicrobial Properties. Molecules (Basel, Switzerland) 27 (12) (2022)
Łukasz Tomorowicz, Beata Żołnowska, Krzysztof Szafrański, Jarosław Chojnacki, Ryszard Konopiński, Ewa A Grzybowska, Jarosław Sławiński, Anna Kawiak
New 2-[(4-Amino-6- N -substituted-1,3,5-triazin-2-yl)methylthio]- N -(imidazolidin-2-ylidene)-4-chloro-5-methylbenzenesulfonamide Derivatives, Design, Synthesis and Anticancer Evaluation. International journal of molecular sciences 23 (13) (2022)
Justyna Stefanowicz-Hajduk, Magdalena Gucwa, Barbara Moniuszko-Szajwaj, Anna Stochmal, Anna Kawiak, J Renata Ochocka
Bersaldegenin-1,3,5-orthoacetate induces caspase-independent cell death, DNA damage and cell cycle arrest in human cervical cancer HeLa cells. Pharmaceutical biology 59 (1) (2021)
Krzysztof Szafrański, Jarosław Sławiński, Łukasz Tomorowicz, Anna Kawiak
Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (E)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides. International journal of molecular sciences 21 (6) (2020)
Łukasz Tomorowicz, Jarosław Sławiński, Beata Żołnowska, Krzysztof Szafrański, Anna Kawiak
Synthesis, Antitumor Evaluation, Molecular Modeling and Quantitative Structure-Activity Relationship (QSAR) of Novel 2-[(4-Amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio]-4-chloro-5-methyl-N-(1H-benzo[d]imidazol-2(3H)-ylidene)Benzenesulfonamides. International journal of molecular sciences 21 (8) (2020)
Paulina Mech, Mariusz Makowski, Anna Kawiak, Agnieszka Chylewska
When biomolecules meet 2-hydrazinopyrazine: from theory through experiment to molecular levels using a wide spectrum of techniques. RSC advances 10 (67) (2020)
Anna Kawiak, Anna Domachowska, Ewa Lojkowska
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction. Journal of natural products 82 (4) (2019)
Grzegorz Fila, Anna Kawiak, Mariusz Stanislaw Grinholc
Blue light treatment of Pseudomonas aeruginosa: Strong bactericidal activity, synergism with antibiotics and inactivation of virulence factors. Virulence 8 (6) (2016)